Skip to main content
Equibles

Edward Tenthoff

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About Edward Tenthoff

Edward Tenthoff is recorded as Analyst at Piper Sandler. Edward Tenthoff has spoken on 11 earnings calls and 1 other investor event across 6 companies, most recently for Legend Biotech Corp on August 11, 2026. Those appearances were for CytomX Therapeutics, Inc. (CTMX), Arrowhead Pharmaceuticals, Inc. (ARWR), Opko Health, Inc. (OPK), Legend Biotech Corp (LEGN), Arvinas, Inc. (ARVN) and 1 other company. The companies whose calls Edward Tenthoff spoke on are classified in the Healthcare sector.

Edward Tenthoff on recent calls

“And thanks for the updates on the Envivo side and all the great progress with Carvicti. My question has to do with the rest of the pipeline, sort of the allogeneic approaches.”
Analyst — Piper Sandler, Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results ·
“And I really just have to say congratulations on the success across the board from team to clinical to really everything.”
Analyst — Piper Sandler, Earnings conference call (announced in 8-K) ·
“I just wanted to retreat a little bit and go back through sort of what the plans are for marketing now that you're approved in U.S., Canada, Austria, and Europe.”
Analyst — Piper Sandler, Arrowhead Pharmaceuticals, Inc. Q3 FY2026 Earnings Call ·
“Thank you very much, and I'm looking forward to more data this year, and congrats on all So, I'll ask about SDMA and 227, really interesting mechanism here.”
Analyst — Piper Sandler, Arvinas, Inc. Q2 FY2026 Earnings Call ·
“I'm really excited to hear about all the progress with the pipeline, and in particular excited about the In Vivo Quartia. I think that could be really differentiated.”
Analyst — Piper Sandler, Q2 2026 Financial Results Conference Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity